Next Biomedical Co.,Ltd. (KOSDAQ:389650)
South Korea · Delayed Price · Currency is KRW 31,750
-1,450 (-4.37%)
At close: Oct 2, 2026
Next Biomedical Market Cap
Next Biomedical has a market cap or net worth of 262.8 billion as of October 2, 2026. Its market cap has decreased by -53.40% in one year.
Market Cap
262.80B
Enterprise Value
234.77B
Revenue
17.79B
Ranking
n/a
PE Ratio
1,130.04
Stock Price
31,750.00
ChartMarket Cap Chart
Since August 20, 2024, Next Biomedical's market cap has increased from 189.79B to 262.80B, an increase of 38.47%. That is a compound annual growth rate of 16.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 262.80B | -64.17% |
| Dec 30, 2025 | 733.43B | 121.21% |
| Dec 30, 2024 | 331.55B | 74.69% |
| Aug 20, 2024 | 189.79B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ASTERASYS Co.,Ltd | 239.69B |
| MEDIANA Co.,Ltd | 187.46B |
| Mezoo | 142.20B |
| L&K Biomed | 138.80B |
| Remed | 78.41B |
| Hironic | 77.65B |
| SELVAS Healthcare | 68.41B |
| DRGEM | 56.44B |